Mirum Pharmaceuticals Stock Analysis

Mirum Stock Analysis Notes

About 98.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 2.08. Mirum Pharmaceuticals had not issued any dividends in recent years. Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. Mirum Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Foster City, California. Mirum Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 171 people. To find out more about Mirum Pharmaceuticals contact Christopher Peetz at 650 667 4085 or learn more at https://www.mirumpharma.com.

Mirum Pharmaceuticals Investment Alerts

Mirum Pharmaceuticals Upcoming and Recent Events

Mirum Largest EPS Surprises

View All Earnings Estimates

Mirum Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

Mirum Pharmaceuticals Thematic Classifications

Mirum Stock Institutional Investors

Note, although Mirum Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Mirum Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.35 B.

Mirum Profitablity

The company has Profit Margin (PM) of (0.33) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.14) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.14.

Management Efficiency

Mirum Pharmaceuticals has return on total asset (ROA) of (0.091) % which means that it has lost $0.091 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3984) %, meaning that it created substantial loss on money invested by shareholders. Mirum Pharmaceuticals' management efficiency ratios could be used to measure how well Mirum Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of the 2nd of February 2025, Return On Tangible Assets is likely to drop to -0.5. In addition to that, Return On Capital Employed is likely to drop to -0.24. At this time, Mirum Pharmaceuticals' Debt To Assets are very stable compared to the past year. As of the 2nd of February 2025, Fixed Asset Turnover is likely to grow to 88.50, while Other Assets are likely to drop 1.09.

Technical Drivers

As of the 2nd of February, Mirum Pharmaceuticals secures the Risk Adjusted Performance of 0.1235, mean deviation of 1.83, and Downside Deviation of 2.26. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mirum Pharmaceuticals, as well as the relationship between them. Please verify Mirum Pharmaceuticals variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Mirum Pharmaceuticals is priced some-what accurately, providing market reflects its recent price of 48.44 per share. Given that Mirum Pharmaceuticals has jensen alpha of 0.3315, we recommend you to check Mirum Pharmaceuticals's last-minute market performance to make sure the company can sustain itself at a future point.

Mirum Pharmaceuticals Price Movement Analysis

Mirum Pharmaceuticals Insider Trading Activities

Mirum Pharmaceuticals Outstanding Bonds

Mirum Pharmaceuticals Predictive Daily Indicators

Mirum Pharmaceuticals Corporate Filings

Mirum Pharmaceuticals Forecast Models

Mirum Pharmaceuticals' time-series forecasting models are one of many Mirum Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Mirum Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Mirum Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Mirum shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Mirum Pharmaceuticals. By using and applying Mirum Stock analysis, traders can create a robust methodology for identifying Mirum entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Mirum analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Mirum analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Mirum Pharmaceuticals stock analysis indicators help investors evaluate how Mirum Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Mirum Pharmaceuticals shares will generate the highest return on investment. By understating and applying Mirum Pharmaceuticals stock analysis, traders can identify Mirum Pharmaceuticals position entry and exit signals to maximize returns.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mirum Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Mirum Stock, please use our How to Invest in Mirum Pharmaceuticals guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mirum Pharmaceuticals. If investors know Mirum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mirum Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Mirum Pharmaceuticals is measured differently than its book value, which is the value of Mirum that is recorded on the company's balance sheet. Investors also form their own opinion of Mirum Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Mirum Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mirum Pharmaceuticals' market value can be influenced by many factors that don't directly affect Mirum Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Mirum Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mirum Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mirum Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.